Vincent Liu

Vincent Liu is an accomplished professional with a strong background in both investment and scientific research. Currently serving as an Investment Intern at RTW Investments, LP, Liu is engaged with the Therapeutics Asset Selection team. Prior experience includes a Graduate Researcher role at Stanford University School of Medicine, focusing on the epigenetics and lineage of innate immune cells in human cancers, and an Investment Fellow position at Vida Ventures, LLC, where responsibilities centered on public and private therapeutics companies. Liu's contributions at Genesis Therapeutics involved business development and strategy, including pipeline management and securing substantial partnerships, while earlier roles at Cartography Biosciences and Memorial Sloan Kettering Cancer Center provided foundational experience in computational biology and cancer research. Liu holds a PhD in Genetics from Stanford University and a Bachelor of Science in Computer Science and Statistics from Columbia University.